Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  López Causapé, Carla ^a   Sommer, Lea Mette ^b   Cabot, Gabriel ^a   Rubio, Rosa ^a   Ocampo Sosa, Alain A ^c   Johansen, Helle Krogh ^b   Figuerola, Joan ^a   Cantón, Rafael ^d   Kidd, Timothy J ^e   Molin, Soeren ^b   Oliver, Antonio ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b Chalmers University of Technology   (Denmark)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN BINDING PROTEIN; POLYMYXIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; AUSTRALIA; BETA-LACTAM RESISTANCE; CYSTIC FIBROSIS; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; PHYLOGENY; PREVALENCE; PSEUDOMONAS AERUGINOSA; SPAIN;

AUSTRALIA; BETA-LACTAM RESISTANCE; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PENICILLIN-BINDING PROTEINS; PHYLOGENY; POLYMYXINS; PREVALENCE; PSEUDOMONAS AERUGINOSA; SPAIN;

EID: 85025116852     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05621-5     Document Type: Article

References (65)

1. Folkesson, A. et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: An evolutionary perspective. Nat Rev Microbiol 10, 841-51 (2012).
2. Rodríguez-Rojas, A., Oliver, A., Blázquez, J. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections. J Infect Dis. 05, 121-7 (2012).
3. Hogardt, M., Heesemann, J. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol. 300, 557-62 (2010).
4. Breidenstein, E. B., de la Fuente-Núñez, C., Hancock, R. E. Pseudomonas aeruginosa: All roads lead to resistance. Trends Microbiol. 19, 419-426 (2011).
5. Silby, M. W., Winstanley, C., Godfrey, S. A., Levy, S. B., Jackson, R. W. Pseudomonas genomes: Diverse and adaptable. FEMS Microbiol. Rev. 35, 652-680 (2011).
6. Aghazadeh, M. et al. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Infect Genet Evol. 24, 187-92 (2014).
7. Ciofu, O., Riis, B., Pressler, T., Poulsen, H. E., Høiby, N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother. 49, 2276-82 (2005).
8. Oliver, A. Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. Int J Med Microbiol. 300, 563-72 (2010).
9. Mena, A. et al. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol. 190, 7910-7 (2008).
10. Oliver, A., Cantón, R., Campo, P., Baquero, F., Blázquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 288, 1251-4 (2000).
11. Pedersen, S. S., Koch, C., Hoiby, N., Rosendal, K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother. 17, 505-516 (1986).
12. Cheng, K. et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 348, 639-642 (1996).
13. Armstrong, D. et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol. 41, 2266-2267 (2003).
14. Winstanley, C., O'Brien, S., Brockhurst, M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 24, 327-37 (2016).
15. Oliver, A., Mena, A., Macià, M. D. Evolution of Pseudomonas aeruginosa pathogenicity: From acute to chronic infections. In: Baquero, F., Nombela, C., Cassell, G. H., Gutiérrez, J. A. (Eds), Evolutionary Biology of Bacterial and Fungal Pathogens, ISBN 978-1-55581-414-4, 433-444, (ASM Press, 2008).
16. López-Causapé, C. et al. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. PLoS One. 8, e71001, doi: 10.1371/journal.pone.0071001 (2013).
17. Garciá-Castillo, M. et al. Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient. J Clin Microbiol. 50, 1777-8 (2012).
18. Kidd, T. J., Grimwood, K., Ramsay, K. A., Rainey, P., Bell, S. C. Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples. J Clin Microbiol. 49, 263-268 (2011).
19. Freschi, L. et al. Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Front Microbiol. 6, 1036 (2015).
20. Treangen, T. J., Ondov, B. D., Koren, S., Phillippy, A. M. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 15, 524 (2014).
21. Williams, D. et al. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. Am J Respir Crit Care Med. 191, 775-785 (2015).
22. Jeukens, J. et al. Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients. PLoSOne. 9, e87611, doi: 10.1371/journal.pone.0087611 (2014).
23. Yang, L. et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA. 108, 7481-6 (2011).
24. Feliziani, S. et al. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet. 10, e1004651, doi: 10.1371/journal.pgen.1004651 (2014).
25. Marvig, R. L., Johansen, H. K., Molin, S., Jelsbak, L. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 9, e1003741, doi: 10.1371/journal.pgen.1003741 (2013).
26. Cramer, N. et al. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ Microbiol. 13, 1690-704 (2011).
27. Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18, 268-81 (2012).
28. Zankari, E. et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 67, 2640-2644 (2012).
29. Maciá, M. D. et al. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother. 49, 3382-6 (2005).
30. Cabot, G. et al. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: Prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother. 55, 1906-1911 (2011).
31. Moyà, B. et al. Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 5, e1000353, doi: 10.1371/journal.ppat.1000353 (2009).
32. Diáz-Caballero, J. et al. Selective sweeps and parallel pathoadaptation drive Pseudomonas aeruginosa evolution in the cystic fibrosis lung. MBio. 6, e00981-15, doi: 10.1128/mBio.00981-15 (2015).
33. Cabot, G. et al. Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates. Antimicrob Agents Chemother. 60, 1767-1778 (2016).
34. Han, S. et al. Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 107, 22002-22007 (2010).
35. Cabot, G. et al. Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing. Antimicrob Agents Chemother. 60, 7415-7423 (2016).
36. Kos, V. N. et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother. 59, 427-36 (2015).
37. Vettoretti, L. et al. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 53, 1987-97 (2009).
38. Poole, K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 49, 479-87 (2005).
39. Hocquet, D. et al. MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother. 47, 1371-5 (2003).
40. Prickett, M. H. et al. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene. Thorax. 72, 40-47 (2017).
41. Vogne, C., Aires, J. R., Bailly, C., Hocquet, D., Plésiat, P. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 48, 1676-80 (2004).
42. Feng, Y., Jonker, M. J., Moustakas, I., Brul, S., Ter Kuile, B. H. Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics. Antimicrob Agents Chemother. 60, 4229-36 (2016).
43. Schurek, K. N. et al. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52, 4213-4219 (2008).
44. El'Garch, F., Jeannot, K., Hocquet, D., Llanes-Barakat, C., Plésiat, P. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother. 51, 1016-21 (2007).
45. Greipel, L. et al. Molecular epidemiology of mutations in antimicrobial resistance loci of Pseudomonas aeruginosa isolates from airways of cystic fibrosis patients. Antimicrob Agents Chemother. 60, 6726-6734 (2016).
46. Poole, K. et al. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol. 21, 713-724 (1996).
47. Mulet, X. et al. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. Antimicrob Agents Chemother. 55, 4560-4568 (2011).
48. Takenouchi, T., Sakagawa, E., Sugawara, M. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones. Antimicrob Agents Chemother. 43, 406-9 (1999).
49. Tomaras, A. P. et al. LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens. MBio. 5, e01551-14, doi: 10.1128/mBio.01551-14 (2014).
50. Gutu, A. D. et al. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. Antimicrob Agents Chemother. 57, 2204-15 (2013).
51. Fernández, L. et al. The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS. Antimicrob Agents Chemother. 56, 6212-22 (2012).
52. Moskowitz, S. M. et al. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother. 56, 1019-30 (2012).
53. Miller, A. K. et al. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother. 55, 5761-9 (2011).
54. Fernández, L. et al. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother. 54, 3372-82 (2010).
55. Lee, J. Y. et al. Development of colistin resistance in pmrA-, phoP-, parR-A nd cprR-inactivated mutants of Pseudomonas aeruginosa. J Antimicrob Chemother. 69, 2966-71 (2014).
56. Barrow, K., Kwon, D. H. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 53, 5150-4 (2009).
57. Juan, C., Moyá, B., Pérez, J. L., Oliver, A. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues. Antimicrob Agents Chemother. 50, 1780-7 (2006).
58. Marvig, R. L., Sommer, L. M., Molin, S., Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 47, 57-64 (2015).
59. Langmead, B., Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods. 9, 357-9 (2012).
60. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 25, 2078-9 (2009).
61. DePristo, M. A. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43, 491-8 (2011).
62. Zerbino, D. R., Birney, E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18, 821-9 (2008).
63. Kurtz, S. et al. Versatile and open software for comparing large genomes. Genome Biol. 5, R12 (2004).
64. Drummond, A. J., Suchard, M. A., Xie, D., Rambaut, A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29, 1969-1973 (2012).
65. Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 6, 80-92 (2012).